Univasc and inflammation Patient Reports February 10, 2012

Univasc Side Effects Report #5368652-X
Univasc side effect was reported by a Consumer or non-health professional from UNITED STATES on June 22, 2006. Male patient, 64 years of age, weighting 179.0 lb, was diagnosed with hypertension and was treated with Univasc. After drug was administered, patient experienced the following side effects: blood pressure inadequately controlled, hormone level abnormal, hypertension, inflammation, renal disorder. Univasc dosage: 15MG, 1 IN 1 D, ORAL. During the same period patient was treated with GLYBURIDE, ROSIGLITAZONE MALEATE, AZATHIOPRINE, WARFARIN, DIGOXIN, FOLIC ACID, FUROSEMIDE, CLONIDINE. Patient recovered.